FIELD: chemistry of peptide compounds.
SUBSTANCE: invention relates to chemically modified peptides with antioxidant activity. The essence of the claimed technical solution is derivatives of the synthetic tetrapeptide Tyr-DArg-Phe-Lys, modified with a TPP group, with a linker length of three to five carbon atoms which have antioxidant activity against living cells, primarily human cells.
EFFECT: invention can be used in various fields of medicine, veterinary medicine and pharmacy, for example, to inhibit the level of reactive oxygen species in cells.
1 cl, 4 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR REDUCTION OF OXIDISING INJURY (VERSIONS) | 2005 |
|
RU2376028C2 |
| CATIONIC TETRAPEPTIDE Phe-D-Arg-Phe-Lys-NH AS MITOCHONDRIAL NITROGEN OXIDE SYNTHASE INHIBITOR | 2015 |
|
RU2587062C1 |
| METHOD FOR TREATING OR PREVENTING CANCER DISEASE IN INDIVIDUAL, WHICH IS CHARACTERISED BY HIGH-LEVEL EXPRESSION OR ACTIVITY OF Gadd45β (AS COMPARED TO COMMON CIVILISED CELLS) IF CANCER CELL VIABILITY AND/OR GROWTH ARE/IS STATED DEPENDENT ON NF-kB, AND TRIPEPTIDE | 2010 |
|
RU2577311C2 |
| PEPTIDE FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION | 2017 |
|
RU2788083C2 |
| PEPTIDE OR ITS ORGANIC OR INORGANIC SALTS, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHODS OF GROWTH HORMONE RELEASE STIMULATION AND ITS BLOOD CONTENT INCREASE | 1992 |
|
RU2126014C1 |
| MODIFIED MITOCHONDRIA AND THEIR USE | 2019 |
|
RU2811467C2 |
| ALPHA-MELANOTROPIN PEPTIDE ANALOGUES | 2009 |
|
RU2496786C2 |
| ADAMANTIL DERIVATIVES OF SHORT PEPTIDES WITH ANTITUMOUR ACTIVITY | 2016 |
|
RU2646795C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING AS AN ACTIVE INGREDIENT A FUSED PROTEIN IN WHICH A TUMOR-PENETRATING PEPTIDE AND AN ANTIANGIOGENIC AGENT ARE FUSED FOR PREVENTING AND TREATING CANCER OR ANGIOGENESIS-RELATED DISEASES | 2016 |
|
RU2727238C2 |
| PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS | 2010 |
|
RU2627065C2 |
